logo

For the Inventor, By the Inventor

Maharashtra, India

Sun Pharma Advanced Research Company Limited


USPTO Granted Patents = 64



Trademarks = 32

Forward Citations = 291

Loading Chart...
Loading Chart...

112 inventors (with patents filed for the assignee):

goldMedal Nitin Bhalachandra Dharmadhikari (20 out of 26 patents)

silverMedal Yashoraj Rupsinh Zala (20 out of 21 patents)

bronzeMedal Ajay Khopade (17 out of 17 patents)

4.  Arindam Halder (13 out of 13 patents)

5.  Trinadha Rao Chitturi (11 out of 18 patents)

6.  Subhas Balaram Bhowmick (8 out of 41 patents)

7.  Rajamannar Thennati (8 out of 43 patents)

8.  Prabal Sengupta (6 out of 6 patents)

9.  Jayraj Dilipbhai Aradhye (5 out of 5 patents)

10.  Bhavesh Mohanbhai Panchal (5 out of 5 patents)

11.  Gaurav Sanjivkumar Sheth (5 out of 5 patents)

12.  Satish Madhukar Gokhale (5 out of 5 patents)

13.  Abhijit Takale (4 out of 25 patents)

14.  Bramhanand Hanamannavar (4 out of 4 patents)

15.  Prashant Kane (4 out of 33 patents)


Core Competencies:
Ophthalmic Solutions
Bioavailability Enhancement
Drug Delivery Systems
Parkinson's Disease Treatment
Heterocyclic Antiestrogens
Abuse Deterrent Formulations
Nanoparticulate Compositions
Prostaglandin Compositions
Stable Multiparticulate Formulations
Cysteinyl Leukotriene Antagonists
S1P1 Receptor Agonists
Amorphous Dispersion

64 patents:

1. 12409175 - Method of increasing bioavailability and/or prolonging ophthalmic action of a drug (2025-09-09),
2. 12383496 - Ophthalmic solution of difluprednate (2025-08-12),
3. 12194153 - Amorphous dispersion of 4-methyl-3-quinolin-3-ylethynyl-benzoic acid n'-(2-chloro-6-methyl-benzoyl) hydrazide (2025-01-14),
4. 11951106 - Method of increasing bioavailability and/or prolonging ophthalmic action of a drug (2024-04-09),
5. 11931359 - Method of increasing bioavailability and/or prolonging ophthalmic action of a drug (2024-03-19),
6. 11890375 - Ophthalmic solution of difluprednate (2024-02-06),
7. 11857683 - Stabilization of phenobarbital sodium for injection (2024-01-02),
8. 11813252 - Treatment for Parkinson's disease (2023-11-14),
9. 11583522 - Treatment for Parkinson's disease (2023-02-21),
10. 11559487 - Drug loaded nanoresin particles (2023-01-24),
11. 11465990 - Heterocyclic antiestrogens (2022-10-11),
12. 11439600 - Abuse deterrent oral solid dosage form (2022-09-13),
13. 11351123 - Amorphous dispersion of 4-methyl-3-quinolin-3-ylethynyl-benzoic acid n'-(2-chloro-6-methyl-benzoyl) hydrazide (2022-06-07),
14. 11304898 - Method of treating carcinoma (2022-04-19),
15. 11273126 - Amorphous dispersion of cyclopropanecarboxylic acid (5-{5-[N'-(2-chloro-6-methylbenzoyl) hydrazinocarbonyl]-2-methyl-phenylethynyl}-pyridin-2-yl) amide (2022-03-15),
Sun Pharma Advanced Research Company Limited (SPARCL) is a research-based global pharmaceutical company that focuses on developing innovative products and solutions in various therapeutic areas. With a commitment to quality and patient care, SPARCL strives to make a positive impact on healthcare. For more information, visit their website.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 16 2025

...
64 Patents

#1 in Maharashtra

#29 in India

#11,015 in the World

...
Maharashtra, India

Sun Pharma Advanced Research Company Limited

Forward Citations = 291

112 inventors:

goldMedal Nitin Bhalachandra Dharmadhikari (20 out of 26 patents)

silverMedal Yashoraj Rupsinh Zala (20 out of 21 patents)

bronzeMedal Ajay Khopade (17 out of 17 patents)

4.  Arindam Halder (13 out of 13 patents)

5.  Trinadha Rao Chitturi (11 out of 18 patents)

Please report any incorrect information to support@idiyas.com
Loading…